Sign in
Companies / MRK vs JNJ

MRK vs JNJ: Merck and Johnson & Johnson

Pharmaceuticals
Compare more companies

Merck (MRK) reported $65.0B in revenue against a 28.1% net margin, while Johnson & Johnson (JNJ) reported $94.2B at a 28.5% net margin, most recently.

MetricMRKJNJ
Revenue$65.0B$94.2B
Net Income$18.3B$26.8B
Gross Margin74.8%67.9%
Operating Margin——
EPS (Diluted)$7.28$11.03
Free Cash Flow$12.4B$19.7B
Total Debt$49.3B$49.9B
P/E Ratio14.5×18.8×
P/B Ration/mn/m
Stock Price$147.90$272.48
Free: last 5 years
Fiscal yearFY2007 🔒FY2008 🔒FY2010 🔒FY2011 🔒FY2012 🔒FY2013 🔒FY2014 🔒FY2016 🔒FY2017 🔒FY2018 🔒FY2019 🔒FY2021FY2022FY2023FY2024FY2025
MRK Revenue•••••••••••••••••••••••••••••••••••••••••••••••••••••••$48.7B$59.3B$60.1B$64.2B$65.0B
JNJ Revenue•••••••••••••••••••••••••••••••••••••••••••••••••••••••$82.6B$78.7B$85.2B$88.8B$94.2B

More on MRK

More on JNJ

Other comparisons